Boehringer Ingelheim receives import permit for avian metapneumovirus vaccine

DULUTH, Ga. — Boehringer Ingelheim announces that the USDA has granted it a permit allowing for importation of its TUR-3 (Newcastle disease, avian paramyxovirosis type 3 and turkey rhinotracheitis, killed virus) vaccine.

TUR-3, a killed vaccine currently licensed for use throughout Europe, will be available for primary vaccination of U.S. turkey and chicken flocks against avian metapneumovirus subtype B. Avian metapneumovirus can result in severe respiratory symptoms and increased mortality in poultry as well as a decrease in egg production, the company notes.

“U.S. poultry producers have been challenged by avian metapneumovirus, and it’s positive news that our TUR-3 vaccine will be available as a tool to support USDA and industry efforts to protect flocks against this highly contagious respiratory disease,” Steve Boren, head of the Boehringer Ingelheim U.S. Livestock and Equine business, said.

“At Boehringer Ingelheim, prevention isn’t just a concept – it’s the very foundation of our company,” Boren added. “We understand that disease outbreaks not only impact poultry health, but also the livelihoods of producers and the security of our food supply. TUR-3 is a proven vaccine and a valuable tool for poultry producers. It works by protecting the health and productivity of flocks.”

Boehringer responded to a request by the USDA Center for Veterinary Biologics for vaccines to protect against the virus. There is no vaccine currently licensed in the U.S. to address this disease challenge.

“By leveraging the Boehringer global supply network, we were able to respond to USDA’s call for vaccines and support poultry producers who have been impacted by the virus,” Boren noted. “We are steadfast in our commitment to delivering solutions that safeguard the health of poultry, and this import permit brings us one step closer to that goal. We are eager to continue our collaboration with USDA and poultry producers across the U.S., contributing to a healthier future for all.”

TUR-3 is expected to be available in the U.S. in November. It is permitted for use domestically in turkeys and chickens. For more information, visit www.boehringer-ingelheim.com/us.

READ MORE: Poultry Today Archives - poultrytimes.com